Vir Biotechnology, Inc. (VIR)
9.36
+0.27
(+2.97%)
USD |
NASDAQ |
Mar 02, 15:29
Vir Biotechnology Free Cash Flow : -396.61M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Hims & Hers Health, Inc. | 57.42M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
| Xeris Biopharma Holdings, Inc. | 9.975M |
| Gossamer Bio, Inc. | -158.51M |
| Sensei Biotherapeutics, Inc. | -24.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.88M |
| Cash from Investing (Quarterly) | 86.65M |
| Cash from Financing (Quarterly) | 1.039M |
| Free Cash Flow Per Share (Quarterly) | -0.1883 |
| Free Cash Flow to Equity (Quarterly) | -23.90M |
| Free Cash Flow to Firm (Quarterly) | -26.22M |
| Free Cash Flow Yield | -30.59% |